canada pharmacy semaglutide Generic to hit Canadian pharmacies this week at lower cost Health Canada warns about fake

The company said in a later investor presentation that its decision to start the phase three trials was based on data including real-world evidence studies showing lower risks of dementia among people on GLP-1 medicines, analyses of effects seen in other clinical trials and animal studies showing that the drugs are associated with improved memory function, reduced neuroinflammation and systemic anti-inflammatory effects

Efficacy and safety of once-weekly semaglutide versus insulin glargine in subjects with type 2 diabetes: the SUSTAIN 4 trial

Guo Y, et, al

Retatrutide and Heart Issues: Cardiovascular Effects, Risks, and Safety Retatrutide and heart issues are a growing focus of clinical interest as this investigational triple agonist advances through trials for obesity and type 2 diabetes